http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2565401-C2
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_86de7d9f2e6454d7c2f6aeaf3b9541b6 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 |
filingDate | 2013-11-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2015-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9476298fe8fa312832665179e9181cf6 |
publicationDate | 2015-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | RU-2565401-C2 |
titleOfInvention | Method of treating diabetes mellitus and combined medication |
abstract | FIELD: medicine. n SUBSTANCE: invention relates to medicine, namely to endocrinology, and deals with treatment of diabetes mellitus. For this purpose pharmaceutical composition, containing activated-potentiated form of antibodies to insulin receptor and activated-potentiated form of antibodies to endothelial NO-synthase, is additionally introduced at the background of treatment of diabetes with insulin and/or hypoglycaemic medications. n EFFECT: method provides increase of treatment efficiency with reduction of dose of insulin and hypoglycaemic medications, which, in its turn, results in reduction of side effects. n 4 cl, 5 ex |
priorityDate | 2013-11-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 144.